Skip to main content
. 2022 Apr 2;13:100127. doi: 10.1016/j.ahjo.2022.100127

Fig. 11.

Fig. 11

- Forest plots for the incidence of pre-specified exploratory CV endpoint occurred in patients on the multiple-dose regimens of inclisiran.